A mechanism of interleukin-12 unresponsiveness associated with thermal injury

被引:22
作者
Utsunomiya, T
Kobayashi, M
Herndon, DN
Pollard, RB
Suzuki, F
机构
[1] Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA
[2] Shriners Burns Hosp, Galveston, TX 77555 USA
关键词
D O I
10.1006/jsre.2001.6088
中图分类号
R61 [外科手术学];
学科分类号
摘要
An unresponsive state for the production of interleukin-12 (IL-12) is commonly observed in animals and patients with severe thermal injuries. In the present study, the participation of corticosteroids, prostaglandin E-2 (PGE(2)), and type 2 cytokines, which appeared in association with thermal injury, on the burn-associated IL-12 unresponsiveness was studied. These substances have been described as inhibitors of IL-12 production. Less than 20 pg/ml serum IL-12 was produced in thermally injured mice (TI-mice) after stimulation with lipopolysaccharide (LPS), while 1037 pg/ml IL-12 was detected in sera of unburned mice equally stimulated with LPS. Almost complete restoration of the impaired IL-12 production was witnessed in TI-mice after treatment with soluble IL-4 receptor (50 ng/mouse, 2 h and 2 days after thermal injury). However, IL-12 was not induced by LPS stimulation in TI-mice treated with an inhibitor of PGE(2) (indomethacin, 0.1-5 mg/kg) or an inhibitor of corticosteroid production (ketoconazole, 10 mg/kg). LPS-stimulated IL-12 production was also impaired in normal mice inoculated with burn-associated type 2 T cells. In addition, in the presence of 1 mug/ml LPS, naive macrophages cocultured with burn-associated type 2 T cells did not produce IL-12 in their culture fluids, while IL-12 was produced by LPS-stimulated naive macrophages that were cocultured with naive splenic CD8(+) T cells. These results suggest that the IL-12-unresponsive state demonstrated in TI-mice is associated mainly with type 2 cytokines released from burn-associated type 2 T cells. (C) 2001 Academic Press.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 46 条
[1]
T-LYMPHOCYTES AND IMMUNOSUPPRESSION IN THE BURNED PATIENT - A REVIEW [J].
BARLOW, Y .
BURNS, 1994, 20 (06) :487-490
[2]
BECKMANN MP, 1992, CHEM IMMUNOL, V51, P107
[3]
INDUCTION OF INTERFERON-GAMMA PRODUCTION BY NATURAL-KILLER-CELL STIMULATORY FACTOR - CHARACTERIZATION OF THE RESPONDER CELLS AND SYNERGY WITH OTHER INDUCERS [J].
CHAN, SH ;
PERUSSIA, B ;
GUPTA, JW ;
KOBAYASHI, M ;
POSPISIL, M ;
YOUNG, HW ;
WOLF, SF ;
YOUNG, D ;
CLARK, SC ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :869-879
[4]
FAIST E, 1986, ARCH SURG-CHICAGO, V121, P1000
[5]
EVIDENCE THAT NATURAL MURINE SOLUBLE INTERLEUKIN-4 RECEPTORS MAY ACT AS TRANSPORT PROTEINS [J].
FERNANDEZBOTRAN, R ;
VITETTA, ES .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (03) :673-681
[6]
FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29
[7]
The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses [J].
Gately, MK ;
Renzetti, LM ;
Magram, J ;
Stern, AS ;
Adorini, L ;
Gubler, U ;
Presky, DH .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :495-521
[8]
IN-VIVO TREATMENT WITH INTERLEUKIN-12 PROTECTS MICE FROM IMMUNE ABNORMALITIES OBSERVED DURING MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (MAIDS) [J].
GAZZINELLI, RT ;
GIESE, NA ;
MORSE, HC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2199-2208
[9]
Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection [J].
Göebel, A ;
Kavanagh, E ;
Lyons, A ;
Saporoschetz, IB ;
Soberg, C ;
Lederer, JA ;
Mannick, JA ;
Rodrick, ML .
ANNALS OF SURGERY, 2000, 231 (02) :253-261
[10]
HANSBROUGH J, 1984, SURGERY, V95, P290